Evidence map›Paper›PMID 33208122›Full record

ArticleBMC medical genetics2020

Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.

Giovanni Brandi, Alessandro Rizzo, Marzia Deserti, Valeria Relli, Valentina Indio, Sofia Bin, Milena Pariali, Andrea Palloni, Stefania De Lorenzo, Francesco Tovoli and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Giovanni BrandiDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy. giovanni.brandi@unibo.it.ORCID 0000-0003-0013-2858
Alessandro RizzoDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Marzia DesertiDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Valeria RelliDepartment of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, via Massarenti 9, 40138, Bologna, Italy.
Valentina Indio"Giorgio Prodi" Cancer Research Center, University of Bologna, Bologna, Italy.
Sofia BinDepartment of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, via Massarenti 9, 40138, Bologna, Italy.
Milena ParialiCenter for Applied Biomedical Research, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Andrea PalloniDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Stefania De LorenzoDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Francesco TovoliDepartment of Medical and Surgical Sciences, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Simona TavolariDivision of Oncology, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITAzienda USL di Bologna · ITUniversity of Bologna · IT

Funding

Fondazione Cassa di Risparmio in Bologna ID: 2015/0300)
6 · The paper itself

Abstract

backgroundPolymorphisms in genes modulating xenobiotics metabolism, in particular the ABCC2 c.3972C > T single nucleotide polymorphism (SNP) at exon 28, have been suggested to increase primary liver cancer (PLC) risk. Conversely, the occurrence of PLCs in Wilson disease patients is a rare event, in contrast with the occurrence observed in other chronic liver diseases. Here we report the clinical case of five siblings carrying the ABCC2 c.3972C > T SNP; three of them were affected by Wilson disease and two brothers with Wilson disease also developed PLCs.

methodsThe presence of the ABCC2 c.3972C > T SNP was assessed by Sanger sequencing and the exposure of PLC risk factors by standardized questionnaires.

resultsNotably, PLCs occurred only in the two brothers with the ABCC2 c.3972C > T SNP and Wilson disease who resulted exposed to asbestos and cigarette smoking, but not in the other siblings with the ABCC2 c.3972C > T SNP, alone or in association with Wilson disease, not exposed to these carcinogens and/or to other known risk factors for PLCs.

conclusionsThese findings suggest that ABCC2 c.3972C > T SNP and WD, also in association, may not represent a sufficient condition for PLC development, but that co-occurrence of further host/exogenous risk factors are needed to drive this process, reinforcing the notion that liver carcinogenesis is the result of a complex interplay between environmental and host genetic determinants. Due to the sporadic cases of this study and the paucity of data currently available in literature on this issue, future investigations in a larger population are needed to confirm our findings.

Indexed as

Polymorphism, Single NucleotideAsbestosATP-Binding Cassette, Sub-Family C ProteinsBase SequenceCarcinoma, HepatocellularCholangiocarcinomaCigarette SmokingExonsFemaleGene-Environment InteractionGene ExpressionHaplotypesHepatolenticular DegenerationHigh-Throughput Nucleotide SequencingHumansLiver CirrhosisABCC2 protein, humanAsbestosATP-Binding Cassette, Sub-Family C ProteinsMultidrug Resistance-Associated Protein 2ABCC2 c.3972C > T polymorphismHepatocellular carcinomaIntrahepatic CholangiocarcinomaRisk factorsWilson disease

Identifiers

PMID33208122
PMCPMC7673086
OpenAlexW3106112728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.